Patients receiving treatment for carpal tunnel syndrome (CTS) prefer to play a more collaborative role when it comes to making decisions about their medical or surgical care, according to the findings of an August 3rd issue of the Journal of Bone and Joint Surgery (JBJS).
“While other studies have shown patients with potentially life-threatening conditions such as cancer tend to prefer a more passive role when it comes to decision-making, this study demonstrates that in carpal tunnel syndrome, which raises issues of quality of life rather than those related to a life-threatening condition, the majority of patients preferred to share decision making with their physicians,” said study author and orthopaedic surgeon Hyun Sik Gong, MD, PhD.Study Details and Findings
According to the study results, patients were more likely to assume an active role in the decision-making process if they:had undergone one or more previous surgical procedures;
Dr. Gong said that previous studies have described three primary approaches to medical decision-making:
And the shared decision-making, or collaborative, model, in which the physician and patient make the decision together and exchange medical and other information related to the patient’s health. Dr. Gong added that previous studies have shown that this type of decision making leads to greater patient satisfaction in medical or surgical treatment.
“This study shows the majority of patients wanted to share decision-making with their physicians, and patients should feel comfortable asking questions and expressing their preferences regarding care. Patient-centered care emphasizes the incorporation of individual styles of decision making to provide a more patient-centered consultation,” Dr. Gong added.
In a ‘patient-centered’ approach, patients’ cultural traditions, personal preferences and values, family situations, social circumstances and lifestyles are considered in the decision-making process.
Patient-centered care presumes active involvement of patients and their families in health care and in decision-making about individual options for treatment, and is identified as one of important factors constituting high-quality health care, Dr. Gong continued.
Although the current study did not determine which type of role, if any, resulted in better surgical outcomes, Dr. Gong said a subsequent study is being conducted evaluating surgical outcomes and patients’ preferred levels of involvement.
“Symptoms and signs of CTS are widely recognized, but the natural history is still unclear,” Dr. Gong said. “There are several treatment options available for CTS, but a discussion between a patient and his or her physician, based upon what activities patients need to pursue will help them achieve their mutual goal of getting back to activities, together. Therefore, the need for patient involvement in CTS is different from the treatment for other orthopaedic conditions such as fractures or bone tumors, where the decision can be more straightforward or depend on the physician’s decision.”
Patients considering treatment of carpal tunnel syndrome or any orthopaedic injury should feel comfortable with their provider’s level of involvement and not be afraid to ask questions or speak up, Dr. Gong noted.
Disclosure: None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of any aspect of this work. None of the authors, or their institution(s), have had any financial relationship, in the thirty-six months prior to submission of this work, with any entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. Also, no author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what is written in this work.
More information on carpal tunnel symptoms and treatment can be found at www.orthoinfo.org
Lauren Pearson | EurekAlert!
GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University
Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy